phase readout
saveNCT06623422: A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Carcinoma, Non-Small-Cell Lung
view source ↗
comments(0)
5-min edit window · permanent after that